Aerie (AERI) Starts Phase II Study on Eye Candidate in Japan

Aerie Pharmaceuticals, Inc. AERI announced that it has initiated the dosing in a phase II study on netarsudil ophthalmic solution in Japan for reducing elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.